Some studies have demonstrated that lncRNA ANRIL regulate the proliferation and apoptosis of vascular smooth muscle cells (VSMCs) and macrophages, thus participant in the development of atherosclerotic plaques; increased expression of ANRIL transcripts was correlated with atherosclerosis risk [7, 8, 9]. This evidence concerns the gene CDKN2B-AS1 and atherosclerosis.